StockData
Quantum Biopharma Ltd. logo

Quantum Biopharma Ltd. (QNTM) stock

QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$1.29−0.13 (-9.15%)

Close on Nov 20, 2026Market cap $5.02MP/E –Yield –

Quantum Biopharma net income

Net income is the profit left for shareholders after every expense, interest and tax.

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2024Sep 30, 2024-$3.83M–
Q3 FY2023Sep 30, 2023-$1.06M–

More Quantum Biopharma figures

See a number that looks wrong?